Afya (NASDAQ:AFYA) Insider Santos Welder Ferreira Sells 4,161 Shares of Company Stock

Key Points

  • Insider sale: Santos Welder Ferreira sold 4,161 Afya shares for approximately $55,341 at an average price of $13.30, reducing his position by 10.63% to 35,000 shares.
  • Financial performance: Afya reported quarterly EPS of $0.43, exceeding the $0.40 consensus estimate, while revenue of $187.8 million fell slightly short of expectations.
  • Market outlook: Analysts have an average “Hold” rating and a $17.75 price target, with one Buy, five Hold, and one Sell rating. Institutional investors own approximately 88.02% of the company.

Afya Limited (NASDAQ:AFYA - Get Free Report) insider Santos Welder Ferreira sold 4,161 shares of the company's stock in a transaction that occurred on Monday, October 5th. The shares were sold at an average price of $13.30, for a total value of $55,341.30. Following the transaction, the insider directly owned 35,000 shares in the company, valued at approximately $465,500. This represents a 10.63% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Afya Price Performance

Shares of AFYA stock opened at $13.91 on Wednesday. The stock has a 50 day moving average price of $13.78 and a 200 day moving average price of $14.26. Afya Limited has a 52-week low of $11.62 and a 52-week high of $16.16. The company has a debt-to-equity ratio of 0.39, a quick ratio of 2.20 and a current ratio of 2.20. The firm has a market capitalization of $1.30 billion, a P/E ratio of 8.48, a P/E/G ratio of 1.49 and a beta of 0.34.

Afya (NASDAQ:AFYA - Get Free Report) last announced its quarterly earnings data on Friday, August 14th. The company reported $0.43 EPS for the quarter, beating the consensus estimate of $0.40 by $0.03. The company had revenue of $187.80 million for the quarter, compared to the consensus estimate of $189.62 million. Afya had a return on equity of 17.58% and a net margin of 20.55%. As a group, sell-side analysts predict that Afya Limited will post 1.86 earnings per share for the current year.

Analyst Ratings Changes




Several analysts have recently weighed in on AFYA shares. JPMorgan Chase & Co. decreased their price target on shares of Afya from $21.50 to $21.00 and set a "neutral" rating for the company in a research note on Monday, June 22nd. Zacks Research lowered Afya from a "hold" rating to a "strong sell" rating in a research report on Friday, August 21st. Weiss Ratings downgraded Afya from a "hold (c)" rating to a "hold (c-)" rating in a research report on Friday, July 31st. Wall Street Zen upgraded Afya from a "hold" rating to a "buy" rating in a report on Saturday, September 5th. Finally, Bank of America reaffirmed a "neutral" rating on shares of Afya in a research note on Thursday, June 11th. One research analyst has rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of "Hold" and an average target price of $17.75.

Check Out Our Latest Analysis on Afya

Institutional Trading of Afya

A number of hedge funds have recently bought and sold shares of AFYA. Public Employees Retirement System of Ohio bought a new stake in Afya during the 2nd quarter valued at $67,000. Engineers Gate Manager LP purchased a new position in shares of Afya in the 2nd quarter valued at $325,000. Finally, Banco BTG Pactual S.A. bought a new position in shares of Afya in the 4th quarter worth $462,000. Hedge funds and other institutional investors own 88.02% of the company's stock.

About Afya

(Get Free Report)

Afya Limited (NASDAQ: AFYA) is a Brazil-based medical education and health technology company. The company provides education and professional development for physicians and other healthcare professionals, with activities spanning undergraduate medical programs, medical residency preparation, specialization courses, continuing medical education and digital learning services.

Afya also develops technology-enabled products designed to support healthcare professionals throughout their careers.

Read More

Insider Buying and Selling by Quarter for Afya (NASDAQ:AFYA)

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Afya?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Afya and related companies.
From Our Partners
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles